Current challenges in cancer gene therapy

Journal of Internal Medicine, Supplement

Volumn 242, Issue 740, 1997, Pages 109-114

  Hwu, P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Gene therapy; Immunotherapy

Indexed keywords

ANTINEOPLASTIC ACTIVITY; CANCER; CANCER GENETICS; CANCER THERAPY; CONFERENCE PAPER; DENDRITIC CELL; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOTHERAPY; MARKER GENE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; GENETICS; IMMUNOLOGY; NEOPLASM; REVIEW;

ANIMALS; GENE THERAPY; HUMANS; IMMUNOTHERAPY; NEOPLASMS; T-LYMPHOCYTES;

EID: 0030629118     PISSN: 09557873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Orkin SH, Motulsky AG. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. NIH Panel Report, 1996.
2. Hwu P. Rosenberg SA. Gene therapy of cancer. In: DeVita VT. Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott-Raven. 1997; 3005-22.